| 8.78 |  -0.03 / -0.34% |
Data as of 4:00pm ET | Day’s Change |
| 8.78 |  0.00 / 0.00% |
Volume: 12,000 |
| Previous close | 8.81 |
| Today’s open | 8.81 |
| Day’s range | 8.69 - 8.95 |
| Volume | 133,493 |
| Average volume (3 months) | 155,815 |
| Market cap | $323.7M |
| Dividend yield | -- |
| Earnings growth (last year) | -225.00% |
| Earnings growth (this year) | +6.15% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | +1.62% |
| P/E ratio | NM |
| Price/Sales | 3.31 |
| Price/Book | 10.11 |
| Today’s change | Today’s % change | |
|---|---|---|
| VASCVascular Solutions I... | +0.06 | +0.39% |
| RTIXRTI Biologics Inc | -0.07 | -1.60% |
| DSCIDerma Sciences Inc | -0.12 | -0.86% |
| ATECAlphatec Holdings In... | +0.03 | +1.56% |
| Next reporting date | August 5, 2013 |
| EPS forecast (this quarter) | $0.03 |
| Annual revenue (last year) | $63.8M |
| Annual profit (last year) | -$1.8M |
| Net profit margin | -2.76% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Barry G. Caldwell |
Vice President- Global Operations Paul Hambrick |
Corporate headquarters Monrovia, California |
.
